Effect of sodium butyrate on kidney and liver mitochondrial dysfunction in a lipopolysaccharide mouse model
The FASEB Journal · 2024
DOI: 10.1096/fj.202401379rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Muznah Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Critical Care Mitochondrial Unit, Nemours Biomedical Research, Nemours Children's Hospital, Wilmington, Delaware, USA. Hauptthemen laut MEDLINE: Lipopolysaccharides, Mice, Inbred C57BL, Butyric Acid, Kidney. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, CHOP Center for Mitochondrial and Epigenomonic Medicine at the Children's Hospital of Philadelphia, Nemours Children's Health.
Abstract (Originalsprache)
Sodium butyrate can reduce inflammation, but it is not known if butyrate can improve mitochondrial dysfunction during sepsis. We tested butyrate to prevent or reverse lipopolysaccharide (LPS)‐induced mitochondrial dysfunction in murine kidney and liver. C57BL/6 mice were grouped as control ( n = 9), intraperitoneal (IP) LPS ( n = 8), pretreatment with IP butyrate 600 ( n = 3) or 1200 mg/kg ( n = 8) followed 2 h later by LPS, posttreatment with IP butyrate 600 ( n = 3) or 1200 mg/kg ( n = 7) 1 h after LPS, or butyrate 1200 mg/kg only ( n = 8). Kidney and liver tissue were collected at 24 h to measure mitochondrial respiration, electron transport system (ETS) complex activity and subunit expression, and content (citrate synthase [CS] activity and mtDNA/nDNA). Kidney mitochondrial respiration was decreased after LPS compared to controls. Pretreatment with butyrate 1200 mg/kg increased kidney OXPHOS CI+II , ETS CI+II , ETS CII , and CIV respiration compared to LPS; posttreatment did not achieve significant increases except for OXPHOS CI . Liver mitochondrial respiration exhibited a similar pattern as in kidney, but differences were not significant. ETS complex and CS activity did not differ between groups, but CI and CII subunit expression trended higher with butyrate in kidney. Changes in mtDNA/nDNA followed a similar pattern as respiration in kidney and liver with a decrease after LPS that was not present with butyrate pretreatment. These data show that butyrate can prevent—but not significantly reverse—the LPS‐induced decrease in kidney mitochondrial respiration without a clear effect in liver. Mitochondrial protection was not attributable to changes in ETS complex activity but may reflect maintenance of ETS subunit expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Critical Care Mitochondrial Unit, Nemours Biomedical Research, Nemours Children's Hospital, Wilmington, Delaware, USA.
- Division of Critical Care, Department of Pediatrics, Nemours Children's Hospital, Wilmington, Delaware, USA.
- Center for Mitochondrial and Epigenomic Medicine at the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Division of Human Genetics, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Department of Pathology, Anatomy, and Cell Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Katherine L Mitchell, Subir Kumar Roy Chowdhury, Douglas C Wallace, Scott L Weiss
Förderung
- NICHD NIH HHS
- CHOP Center for Mitochondrial and Epigenomonic Medicine at the Children's Hospital of Philadelphia
- Nemours Children's Health
- HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Khan, M., Farooqi, S., Mitchell, K. L., Chowdhury, S. K. R., Cabrera-Ayala, M., Huang, J., Wallace, D. C., & Weiss, S. L. (2024). Effect of sodium butyrate on kidney and liver mitochondrial dysfunction in a lipopolysaccharide mouse model. The FASEB Journal. https://doi.org/10.1096/fj.202401379rr
Vancouver
Khan M, Farooqi S, Mitchell KL, Chowdhury SKR, Cabrera-Ayala M, Huang J, et al. Effect of sodium butyrate on kidney and liver mitochondrial dysfunction in a lipopolysaccharide mouse model. The FASEB Journal. 2024. doi:10.1096/fj.202401379rr
BibTeX
@article{Khan2024,
author = {Khan, Muznah and Farooqi, Sumera and Mitchell, Katherine L and Chowdhury, Subir Kumar Roy and Cabrera-Ayala, Marian and Huang, Jessica and Wallace, Douglas C and Weiss, Scott L},
title = {Effect of sodium butyrate on kidney and liver mitochondrial dysfunction in a lipopolysaccharide mouse model},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202401379rr}
}
EUVIMED